LexisNexis® Legal Newsroom
Most FDA Advisers Recommend Avandia Stay On The Market

GAITHERSBURG, Md. - (Mealey's) A majority of Food and Drug Administration advisers voted July 14 to keep Avandia on the market but split on whether the anti-diabetes drug made by GlaxoSmithKline PLC (GSK) should carry additional warnings about its heart risks or that its use be restricted. Twelve...

$2.36B Glaxo Charge Covers Avandia, Paxil Litigation, Other Legal Costs

LONDON - (Mealey's) GlaxoSmithKline PLC (GSK) on July 15 said it expects to take a $2.36 billion charge against earnings to settle several legal issues, including settling "the substantial majority" of Avandia product liability cases and the "vast majority" of Paxil product liability...

Bankruptcy Judge Approves Leslie Controls' Plan Of Reorganization

WILMINGTON, Del. - (Mealey's) The Delaware bankruptcy judge overseeing Leslie Control Inc.'s Chapter 11 case confirmed Leslie's plan of reorganization on Oct. 28 ( In Re: Leslie Controls Inc. , No. 10-12199-CSS, Del. Bkcy.). U.S. Bankruptcy Judge Christopher S. Sontchi of the District...